Goldman Sachs
PRVA icon

Goldman Sachs’s Privia Health PRVA Stock Holding History

Goldman Sachs’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.6M Buy
1,339,950
+445,248
+50% +$10M ﹤0.01% 2134
2025
Q4 		$21.2M Buy
894,702
+258,430
+41% +$6.29M ﹤0.01% 2319
2025
Q3 		$15.8M Buy
636,272
+96,023
+18% +$2.07M ﹤0.01% 2492
2025
Q2 		$12.4M Sell
540,249
-144,224
-21% -$3.34M ﹤0.01% 2565
2025
Q1 		$15.4M Sell
684,473
-240,884
-26% -$5.6M ﹤0.01% 2282
2024
Q4 		$18.1M Buy
925,357
+325,832
+54% +$6.46M ﹤0.01% 2219
2024
Q3 		$10.9M Buy
599,525
+355,120
+145% +$6.78M ﹤0.01% 2618
2024
Q2 		$4.25M Buy
244,405
+82,901
+51% +$1.47M ﹤0.01% 3315
2024
Q1 		$3.16M Buy
161,504
+32,452
+25% +$685K ﹤0.01% 3503
2023
Q4 		$2.97M Buy
129,052
+119,407
+1,238% +$2.67M ﹤0.01% 3606
2023
Q3 		$222K Sell
9,645
-257
-3% -$6.54K ﹤0.01% 5006
2023
Q2 		$259K Sell
9,902
-24,817,619
-100% -$655M ﹤0.01% 5084
2023
Q1 		$685M Buy
24,827,521
+2,930
+0% +$77.3K 0.16% 111
2022
Q4 		$564M Sell
24,824,591
-3,187,612
-11% -$88.7M 0.14% 132
2022
Q3 		$954M Buy
28,012,203
+98,834
+0.4% +$3.65M 0.24% 65
2022
Q2 		$813M Sell
27,913,369
-97,088
-0.3% -$2.47M 0.2% 83
2022
Q1 		$749M Buy
28,010,457
+3,010
+0% +$71.1K 0.16% 104
2021
Q4 		$725M Sell
28,007,447
-2,507,042
-8% -$62.5M 0.14% 118
2021
Q3 		$719M Buy
30,514,489
+860
+0% +$30K 0.15% 115
2021
Q2 		$1.35B Buy
+30,513,629
New +$1.13B 0.3% 46

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Goldman Sachs's PRVA Position: Q1 2026 in Review

Goldman Sachs increased its Privia Health (PRVA) stake by 50% in Q1 2026, buying an estimated $10M and bringing the position to 1,339,950 shares worth $27.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2134.

Goldman Sachs first reported a position in PRVA in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.35B in Q2 2021. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • Goldman Sachs held 1,339,950 shares of Privia Health worth $27.6M as of Q1 2026.
  • Goldman Sachs bought 445,248 Privia Health shares in Q1 2026, an estimated $10M.
  • Privia Health made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2134 holding.
  • Goldman Sachs first reported a position in Privia Health in Q2 2021 and has held it in 20 quarters since.
  • Goldman Sachs's Privia Health position peaked at $1.35B in Q2 2021.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.